Journeys Metabolic

About:

Journeys Metabolic is an interoperable metabolic digital therapeutic platform that enables health systems to transition to value-based care.

Website: https://journeysmetabolic.com

Top Investors: Creative Destruction Lab (CDL), BioGenerator, Missouri Technology Corporation, New York Angels, iSelect Fund

Description:

Journeys Metabolic is a digital solution provider filling the gap of metabolic care beyond PCP office. The in-home, interoperable HITRUST 6-month program for obesity and T2 diabetes reversal enables health systems and ACO's to transition to value-based care with no burden no the care team. Based on five years of sustained behavior modification, the physician-developed program uses AI-enabled precision pathways, computer vision of food for education, and proprietary Biosense biomarker of fat oxidation levels. Journeys Metabolic supports shared savings optimization in boht metabolic diseases and nutrition related disorders with nutritional interventions.

Total Funding Amount:

$3.06M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

St Louis, Missouri, United States

Founded Date:

2018-07-11

Contact Email:

info(AT)jouneysmetabolic.com

Founders:

Allison Hull, D.O., Jim Howard, Kelly Matthew, Tim Ratto

Number of Employees:

11-50

Last Funding Date:

2023-02-20

IPO Status:

Private

Industries:

© 2025 bioDAO.ai